QGEN
Qiagen NV

1,397
Mkt Cap
$9.69B
Volume
866,006.00
52W High
$51.88
52W Low
$37.63
PE Ratio
24.09
QGEN Fundamentals
Price
$44.65
Prev Close
$44.53
Open
$44.35
50D MA
$46.24
Beta
0.59
Avg. Volume
975,230.43
EPS (Annual)
$0.3826
P/B
2.65
Rev/Employee
$343,142.06
Loading...
Loading...
News
all
press releases
Hologic Expands European Reach of Genius Digital Diagnostics System
HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.
Zacks·16h ago
News Placeholder
More News
News Placeholder
Qiagen N.V. $QGEN Shares Sold by Aviva PLC
Aviva PLC reduced its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 60.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·2d ago
News Placeholder
Nuance Investments LLC Sells 1,420,510 Shares of Qiagen N.V. $QGEN
Nuance Investments LLC lessened its holdings in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 51.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned...
MarketBeat·4d ago
News Placeholder
William Blair Has Strong Estimate for Qiagen FY2025 Earnings
Qiagen N.V. (NYSE:QGEN - Free Report) - Equities researchers at William Blair boosted their FY2025 earnings per share estimates for Qiagen in a research note issued on Friday, November 7th. William...
MarketBeat·4d ago
News Placeholder
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the debut of QIAsymphony Connect, the next generation of QIAGENs widely adopted automated nucleic acid purification platform...
Business Wire·4d ago
News Placeholder
Andra AP fonden Invests $1.43 Million in Qiagen N.V. $QGEN
Andra AP fonden purchased a new stake in Qiagen N.V. (NYSE:QGEN - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm...
MarketBeat·5d ago
News Placeholder
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·7d ago
News Placeholder
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·9d ago
News Placeholder
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of +5.17% and +1.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for solid profitable growth while raising its profitability...
Business Wire·9d ago

Latest QGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.